Sanofi SA

Sanofi: Information concerning the total number of voting rights and shares - August 2025

12 9月 2025 09:30:00 条件 Nasdaq GlobeNewswire

Press Release: Sanofi’s SAR402663 earns fast track designation in the US for neovascular age-related macular degeneration

10 9月 2025 22:00:00 条件 Nasdaq GlobeNewswire

Press Release: Tzield approved in China as first disease-modifying therapy for adult and pediatric patients with stage 2 type 1 diabetes

09 9月 2025 22:00:00 条件 Nasdaq GlobeNewswire

Press Release: Sanofi’s amlitelimab met all primary and key secondary endpoints in the COAST 1 phase 3 study in adults and adolescents with atopic dermatitis

03 9月 2025 22:01:00 条件 Nasdaq GlobeNewswire

Press Release: Sanofi’s amlitelimab met all primary and key secondary endpoints in the COAST 1 phase 3 study in adults and adolescents with atopic dermatitis

03 9月 2025 22:00:00 条件 Nasdaq GlobeNewswire

Press Release: Sanofi’s Wayrilz approved in US as first BTK inhibitor for immune thrombocytopenia

29 8月 2025 14:50:16 条件 Nasdaq GlobeNewswire

Sanofi: Information concerning the total number of voting rights and shares - July 2025

18 8月 2025 09:30:00 条件 Nasdaq GlobeNewswire

Press Release: Sanofi’s rilzabrutinib earns orphan designation in the EU for IgG4-related disease

13 8月 2025 22:00:00 条件 Nasdaq GlobeNewswire

Press Release: Sanofi completes the acquisition of Vigil Neuroscience, Inc.

05 8月 2025 22:00:00 条件 Nasdaq GlobeNewswire

Press release: Online availability of Sanofi’s half-year financial report for 2025

31 7月 2025 09:20:00 条件 Nasdaq GlobeNewswire

Press Release: Q2: double-digit sales and solid business EPS growth. 2025 sales guidance is now high single-digit growth, at upper end of range

30 7月 2025 22:30:00 条件 Nasdaq GlobeNewswire

Press Release: Sanofi’s SAR446523, a GPRC5D monoclonal antibody, earns orphan drug designation in the US for multiple myeloma

29 7月 2025 22:00:00 条件 Nasdaq GlobeNewswire

Press Release: Sanofi’s Sarclisa approved in the EU for the treatment of transplant-eligible newly diagnosed multiple myeloma

24 7月 2025 22:00:00 条件 Nasdaq GlobeNewswire

Press Release: Sanofi to acquire Vicebio, expanding respiratory vaccines pipeline

21 7月 2025 22:30:00 条件 Nasdaq GlobeNewswire

Press Release: Sanofi completes acquisition of Blueprint Medicines

17 7月 2025 22:00:00 条件 Nasdaq GlobeNewswire

Press Release: Sanofi announces extension of Blueprint tender offer

16 7月 2025 22:00:00 条件 Nasdaq GlobeNewswire

Press Release: Sanofi’s SAR446597 earns fast track designation in the US for geographic atrophy due to age-related macular degeneration

15 7月 2025 22:00:00 条件 Nasdaq GlobeNewswire

Sanofi: Information concerning the total number of voting rights and shares - June 2025

09 7月 2025 09:29:17 条件 Nasdaq GlobeNewswire

Press release: Availability of the Q2 2025 Aide mémoire

29 6月 2025 22:30:00 条件 Nasdaq GlobeNewswire

Press Release: Riliprubart granted orphan drug designation in Japan for chronic inflammatory demyelinating polyneuropathy

29 6月 2025 22:00:00 条件 Nasdaq GlobeNewswire